The markets extended its losses during the midday with the Dow falling 47 points to 17,879 as crude oil prices dropped. Nasdaq lost 16 points to 4,929.
On the upside
The National Institute for Health and Care Excellence has recommended PTC Therapeutics' (Nasdaq: PTCT) Translarna to treat nonsense mutation Duchenne muscular dystrophy.
First Majestic Silver (NYSE: AG) reported record production of 5.1 million silver equivalent ounces in the first quarter.
Raymond James upgraded Micron Technology (Nasdaq: MU) from an Outperform rating to a Strong Buy rating.
On the downside
Super Micro Computer (Nasdaq: SMCI) warned that third quarter earnings and revenue would fall short of previous guidance.
Bezinga reported that Centerview Partners was no longer advising Relypsa (Nasdaq: RLYP) on a potential sale of the company.
Investors locked in profits on Repros Therapeutics (Nasdaq: RPRX).
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on both the NYSE and on Nasdaq. The broader S&P 500 lost 5 points to 2,077. Bitcoin added $5 to $427.
